Dr. Ed Cheung
Director, Analytical
Leadership
Transferra Nanosciences
Canada
Biography
Dr. Cheung has extensive experience overseeing in-house and contracted bioanalytical development projects at CRO, CMO, and corporate partners in support of pre-clinical and clinical drug development. He has led or participated on teams performing analytical development, validation and method transfer in support of process development, manufacturing, release and stability testing. Dr Cheung has fifteen years CMC experience in biopharmaceutical development of small molecules and biologicals including recombinant proteins, synthetic peptides, monoclonal antibodies, and protein-carbohydrate conjugates. He has hands-on pragmatic knowledge about applying a wide range of analytical techniques to effective and efficient production of a drug article for regulatory approval. Before joining TRANSFERRA Dr.Cheung worked in Quality Assurance and Analytical Chemistry roles for drug development companies such as Genzyme Corporation, INEX Pharmaceuticals Inc., Biomira Inc., and Athena Neurosciences. Dr. Cheung received his chemistry doctorate from Concordia University, Montreal Canada.
Research Interest
Chemistry
